Pregled bibliografske jedinice broj: 264565
Role of angiogenesis in chronic lymphocytic leukemia
Role of angiogenesis in chronic lymphocytic leukemia // Cancer, 107 (2006), 5; 925-934 doi:10.1002/cncr.22086 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 264565 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Role of angiogenesis in chronic lymphocytic leukemia
Autori
Letilović, Tomislav ; Vrhovac, Radovan ; Verstovšek, Srđan ; Jakšić, Branimir ; Ferrajoli, Alexandra
Izvornik
Cancer (0008-543X) 107
(2006), 5;
925-934
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
angiogenesis; chronic lymphocytic leukemia
Sažetak
Angiogenesis is a physiologic process of new blood vessels formation mediated by various cytokines called angiogenic and angiostatic factors. Although its potential pathophysiologic role in solid tumors has been extensively studied for more than 3 decades, enhancement of angiogenesis in chronic lymphocytic leukemia (CLL) and other malignant hematological disorders has been recognized more recently. An increased level of angiogenesis has been documented by various experimental methods both in bone marrow and lymph nodes of patients with CLL. Although the role of angiogenesis in the pathophysiology of this disease remains to be fully elucidated, experimental data suggest that several angiogenic factors play a role in the disease progression. Biologic markers of angiogenesis were also shown to be of prognostic relevance in CLL. The current findings provide the rationale for investigating antiangiogenic agents in CLL. In the current review angiogenesis in CLL is discussed and its potential diagnostic and therapeutic applications.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE